China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Protective Effect of Remote Ischemic Preconditioning Against Contrast-Induced Nephropathy After Peripheral Vascular Endovascular Diagnosis and Therapy'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135826
Registration Time: 2026/11/02
Type: Interventional study
Primary Sponsor: Xuanwu Hospital Capital Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=312145
Published by HT Digital Content Services with permission from Health Daily Digest....